Medtronic touts cost-effectiveness of insertable cardiac monitors
Medtronic (NYSE: MDT) today announced new cost-effectiveness data from a study looking at its Reveal Linq insertable cardiac monitor (ICM).
Stay updated with breaking news from Cardiovascular Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic (NYSE: MDT) today announced new cost-effectiveness data from a study looking at its Reveal Linq insertable cardiac monitor (ICM).
Artificial intelligence is proving effective in early detection and treatment of cardiovascular diseases. In most cases, technology can also outperform the huma
/PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2024 (FY24), which ended October 27, 2023. Key...
Additional lab and animal research presented in the paper revealed that erythritol appeared to be causing blood platelets to clot more readily.
A sugar replacement used in many stevia, monk-fruit, keto and other reduced-sugar products marketed for weight loss and diabetes has been linked to stroke, heart attack and early death, a study found.